Suppr超能文献

累及乳腺和颈部淋巴结的指突状树突细胞肿瘤:1例报告并文献复习

Interdigitating dendritic cell tumor with breast and cervical lymph-node involvement: a case report and review of the literature.

作者信息

Uluoğlu Omer, Akyürek Nalan, Uner Aytuğ, Coşkun Uğur, Ozdemir Ayşegul, Gökçora Nahide

机构信息

Department of Pathology, Gazi University Medical School, Ankara, Turkey.

出版信息

Virchows Arch. 2005 May;446(5):546-54. doi: 10.1007/s00428-005-1209-3. Epub 2005 Apr 2.

Abstract

Interdigitating dendritic cell tumor (IDCT) is an extremely rare malignancy. It occurs primarily in lymph nodes, but extranodal involvement has also been reported. A 38-year-old woman with IDCT with breast and cervical lymph-node involvement is reported in this paper. To our knowledge, this is the first case of IDCT originating from the breast. In the breast and lymph node, the tumor displayed diffuse sheets, fascicles and storiform growth pattern. It was composed of oval to spindle cells with pale to eosinophilic cytoplasm, ill-defined cell outlines, oval nuclei with vesicular chromatin and prominent eosinophilic nucleoli. Mitotic activity was three per ten high-power fields. The neoplastic cells were intermingled with small mature lymphocytes and plasma cells. Immunohistochemical studies showed that the tumor cells were strongly and diffusely positive for vimentin, CD68, S-100 protein, CD45/leukocyte common antigen and fascin and focally positive for lysozyme, alpha-1 antitrypsin and CD4. Ki-67 labeling index was 10%. The patient was treated with combined therapeutic approaches, including surgery, radiotherapy and chemotherapy. IDCT has the potential for an aggressive clinical course. However, 32 months after the initial diagnosis, the patient is still alive and being followed with a stable tumor burden.

摘要

指状突树突状细胞肿瘤(IDCT)是一种极其罕见的恶性肿瘤。它主要发生于淋巴结,但也有结外受累的报道。本文报道了一名38岁患有累及乳腺和颈部淋巴结的IDCT女性患者。据我们所知,这是首例起源于乳腺的IDCT。在乳腺和淋巴结中,肿瘤呈弥漫性片状、束状和席纹状生长模式。它由椭圆形至梭形细胞组成,细胞质淡染至嗜酸性,细胞轮廓不清,椭圆形核,核染色质呈泡状,核仁嗜酸性明显。每10个高倍视野有3个有丝分裂象。肿瘤细胞与小的成熟淋巴细胞和浆细胞混合存在。免疫组织化学研究显示,肿瘤细胞波形蛋白、CD68、S-100蛋白、CD45/白细胞共同抗原和细丝蛋白呈强弥漫性阳性,溶菌酶、α-1抗胰蛋白酶和CD4呈局灶性阳性。Ki-67标记指数为10%。患者接受了包括手术、放疗和化疗在内的综合治疗。IDCT有临床病程侵袭性的可能。然而,在初次诊断32个月后,患者仍然存活,肿瘤负荷稳定,仍在接受随访。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验